isoflurophate has been researched along with naloxone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bethea, CL; Lorens, SA; Paris, J; Richardson, KD; Urban, JH; Van de Kar, LD | 1 |
| Costa, LG; Murphy, SD | 1 |
| Bhargava, HN; Way, EL | 1 |
| Baker, WW; Kratky, M; Young, RL | 1 |
| Henderson, G; Karczmar, AG; Koehn, GL | 1 |
| Buccafusco, JJ; Zhang, LC | 1 |
| Buccafusco, JJ; Gattu, M; Jonnala, RR; Shuster, LC; Zhang, LC | 1 |
7 other study(ies) available for isoflurophate and naloxone
| Article | Year |
|---|---|
Pharmacological studies on stress-induced renin and prolactin secretion: effects of benzodiazepines, naloxone, propranolol and diisopropyl fluorophosphate.
Topics: Animals; Benzodiazepines; Chlordiazepoxide; Isoflurophate; Juxtaglomerular Apparatus; Male; Midazolam; Naloxone; Pituitary Gland, Anterior; Prolactin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, GABA-A; Renin; Stress, Psychological | 1985 |
Cholinergic and opiate involvement in the antinociceptive effect of diisopropylfluorophosphate.
Topics: Analgesics; Animals; Body Temperature; Brain; Cholinesterases; Disulfoton; Isoflurophate; Male; Mice; Naloxone; Parasympathetic Nervous System; Reaction Time; Receptors, Opioid; Scopolamine; Time Factors | 1986 |
Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice.
Topics: Animals; Brain; Cholinesterase Inhibitors; Drug Interactions; Drug Tolerance; Humans; Isoflurophate; Kinetics; Male; Mice; Morphine; Morphine Dependence; Naloxone; Physostigmine | 1972 |
Acute effects of hydromorphone on chemically-induced repetitive discharges in the hippocampus.
Topics: Animals; Cats; Cholinesterase Inhibitors; Decamethonium Compounds; Dose-Response Relationship, Drug; Hippocampus; Injections, Intravenous; Isoflurophate; Male; Morphinans; Naloxone; Picrotoxin | 1974 |
Di-isopropyl phosphofluoridate-induced antinociception: possible role of endogenous opioids.
Topics: Analgesics; Animals; Body Temperature; Dose-Response Relationship, Drug; Drug Tolerance; Endorphins; Isoflurophate; Male; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Nociceptors; Rats; Receptors, Opioid; Stereoisomerism; Time Factors | 1980 |
Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Disease Models, Animal; Infusions, Intravenous; Injections, Subcutaneous; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Substance Withdrawal Syndrome; Vasomotor System | 1998 |
Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats.
Topics: Acetylcholinesterase; Animals; Arecoline; Blood Pressure; Brain; Cardiovascular System; Cholinergic Fibers; Cholinesterase Inhibitors; Drug Administration Schedule; Echothiophate Iodide; Heart Rate; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2000 |